Zolpidem stimulant effect: Induced mania case report and systematic review of cases
ConclusionsThe latest FDA recommendations for lowering zolpidem doses should be adopted by all countries. Zolpidem prescriptions should be contraindicated for populations with identified risk factors.
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research
More News: Addiction | Ambien | Anxiety | Bipolar | Brain | Depression | France Health | Germany Health | International Medicine & Public Health | Italy Health | Mania | Neurology | Neuroscience | Psychiatry | Science | Spain Health | Study | Substance Abuse | WHO